INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 29 giu 2020
Pagine: 23 - 26
Ricevuto: 11 nov 2019
Accettato: 10 feb 2020
DOI: https://doi.org/10.2478/jim-2020-0001
Parole chiave
© 2020 Lucian Gheorghe Pop et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Acute fatty liver of pregnancy (AFLP) is a rare but life-threatening condition that develops in the third trimester of pregnancy. AFLP shares similar clinical features with other more common pregnancy-associated conditions. However, early correct diagnosis is important for maternal and fetal survival. Once the diagnosis has been established, immediate delivery and maternal intensive support should be undertaken. Both parents and the infant should be tested for deficiencies of the mitochondrial fatty acid oxidation, especially for long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, as many cases of AFLP are related to disruption of this physiological enzymatic pathway.